Crown Electrokinetics Files Annual Proxy Statement

TL;DR

CRKN filed its DEF 14A proxy statement, no fee required. Annual meeting details inside.

AI Summary

Crown Electrokinetics Corp. filed a Definitive Proxy Statement (DEF 14A) on May 21, 2024, for its annual meeting. The filing indicates no fee was required for this submission. The company is involved in the ELECTRONIC COMPONENTS, NEC industry.

Why It Matters

This filing provides shareholders with essential information regarding the company's annual meeting, including voting matters and executive compensation, which are crucial for informed shareholder participation.

Risk Assessment

Risk Level: low — This is a routine annual filing (DEF 14A) and does not contain new material financial or operational information that would inherently increase risk.

Key Players & Entities

• Crown Electrokinetics Corp. (company) — Registrant
• 0001761696-24-000021 (filing_id) — Accession Number
• 20240521 (date) — Filing Date

FAQ

Key Financial Figures

• $0.0001 — ck split of our Common Stock, par value $0.0001 per share ("Common Stock"), at a ratio

Filing Documents

• crkn-def14a2024annualmeeti.htm (DEF 14A) — 739KB
• crkn-proxycard2024annual00.jpg (GRAPHIC) — 144KB
• crkn-proxycard2024annual00a.jpg (GRAPHIC) — 103KB
• 0001761696-24-000021.txt ( ) — 1080KB

Gender Identity

Part I Gender Identity Directors — 5 — —

Demographic Background

Part II Demographic Background African American or Black — — — — Alaskan Native or Native American — — — — Asian — 1 — — Hispanic or Latinx — — — — Native Hawaiian or Pacific Islander — — — — White — 4 — — Two or More Races or Ethnicities — — — — LGBTQ+ — — — — Did Not Disclose Demographic Background — — — — If any nominee is unable or unwilling to serve as a director at the time of the Annual Meeting, the proxies may be voted for the balance of those nominees named and for any substitute nominee designated by the current Board of Directors or the proxy holders to fill such vacancy or for the balance of those nominees named without the nomination of a substitute, or the size of the Board of Directors may be reduced in accordance with our Bylaws. Nominees Douglas Croxall. Mr. Croxall is the Chief Executive Officer and Chairman of the Board of Directors of the Company. Prior to co-founding the Company, Mr. Croxall was the CEO and Chairman of the Board of Directors of Marathon Patent Group from November 2012 until December 2017. Mr. Croxall holds a BA degree from Purdue University and an MBA from Pepperdine University. The Company's Board of Directors believes that Mr. Croxall should continue to serve as a member of the Board of Directors due to his executive experience, and his financial, investment, and management experience, which will provide the requisite qualifications, skills, perspectives, and experience that make him well qualified. Dr. DJ Nag . Dr. Nag has served as a member of the Company's Board of Directors since July 2020. Dr. Nag is the Chief Investment Officer at Ventech Solutions, a healthcare technology company that manages quality data for the Center for Medicare and Medicaid Services (CMS). He has successfully led Ohio State University, Rutgers University and University of Nebraska's technology transfer operations that included licensing, startup and 5 investments. As an entrepreneur, he led a number of start-ups in the

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS The following table sets forth certain information regarding the ownership of our Common Stock as of May 14, 2024 (the "Determination Date") by (i) each current director of our company and each director nominee (ii) each of our Named Executive Officers (iii) all current executive officers and directors of our company as a group and (iv) all those known by us to be beneficial owners of more than five percent (5%) of our Common Stock. Beneficial ownership and percentage ownership are determined in accordance with the rules of the SEC. Under these rules, beneficial ownership generally includes any shares as to which the individual or entity has sole or shared voting power or investment power and includes any shares that an individual or entity has the right to acquire beneficial ownership of within 60 days of the Determination Date, through the exercise of any option, warrant or similar right (such instruments being deemed to be "presently exercisable"). In computing the number of shares beneficially owned by a person and the percentage ownership of that person, shares of our Common Stock that could be issued upon the exercise of presently exercisable options and warrants are considered to be outstanding. These shares, however, are not considered outstanding as of the Determination Date when computing the percentage ownership of each other person. To our knowledge, except as indicated in the footnotes to the following table, and subject to state community property laws where applicable, all beneficial owners named in the following table have sole voting and investment power with respect to all shares shown as beneficially owned by them. Unless otherwise indicated, the business address of each person in the table below is co Crown Electrokinetics Corp., at 1110 NE Circle Blvd., Corvallis, Oregon 97330. No shares identified below are subject to a pledge. 7 Common Stock Beneficially Owned Name of Beneficial Owner and

View Full Filing

View this DEF 14A filing on SEC EDGAR